Biotech · Public company · San Diego, CA, US
Heron Therapeutics, Inc.
Ticker HRTX · SEC CIK 0000818033
Track this companyFree. Adds Heron Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials252 recruiting or active
Pipeline programs43From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline43
- +/- Bupivacaine HClPhase 3 · AnalgesiaClinicalTrials.gov · fetched Nov 12, 2026
- AcetaminophenPhase 3 · AnalgesiaClinicalTrials.gov · fetched Nov 12, 2026
- APF530Phase 3 · Chemotherapy-induced Nausea and VomitingClinicalTrials.gov · fetched Nov 12, 2026
- APF530Phase 3 · Nausea and VomitingClinicalTrials.gov · fetched Nov 12, 2026
- Bupivacaine HClPhase 3 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- CelecoxibPhase 3 · AnalgesiaClinicalTrials.gov · fetched Nov 12, 2026
- dexamethasonePhase 3 · Nausea and VomitingClinicalTrials.gov · fetched Nov 12, 2026
- DexamethasonePhase 3 · Chemotherapy-induced Nausea and VomitingClinicalTrials.gov · fetched Nov 12, 2026
- FosaprepitantPhase 3 · Chemotherapy-induced Nausea and VomitingClinicalTrials.gov · fetched Nov 12, 2026
- HTX-011Phase 3 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- HTX-011Phase 3 · AnalgesiaClinicalTrials.gov · fetched Nov 12, 2026
- IbuprofenPhase 3 · AnalgesiaClinicalTrials.gov · fetched Nov 12, 2026
- Luer lock applicatorPhase 3 · AnalgesiaClinicalTrials.gov · fetched Nov 12, 2026
- Luer-lock applicatorPhase 3 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- OndansetronPhase 3 · Chemotherapy-induced Nausea and VomitingClinicalTrials.gov · fetched Nov 12, 2026
- Palonosetron HydrochloridePhase 3 · Nausea and VomitingClinicalTrials.gov · fetched Nov 12, 2026
- Vial access devicePhase 3 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- AcetaminophenPhase 2 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- aprepitantPhase 2 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- Aprepitant injectable emulsionPhase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- Bupivacaine HCI (Marcaine)Phase 2 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- Bupivacaine HCI without epinephrinePhase 2 · Post-Operative PainClinicalTrials.gov · fetched Nov 12, 2026
- Bupivacaine HClPhase 2 · BunionsClinicalTrials.gov · fetched Nov 12, 2026
- Bupivacaine HCl without epinephrinePhase 2 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- Bupivicaine HClPhase 2 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- HTX-002Phase 2 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- HTX-009Phase 2 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- HTX-011Phase 2 · Post-Operative PainClinicalTrials.gov · fetched Nov 12, 2026
- HTX-011APhase 2 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- HTX-011BPhase 2 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- HTX-034 high dosePhase 2 · BunionsClinicalTrials.gov · fetched Nov 12, 2026
- HTX-034 low dosePhase 2 · BunionsClinicalTrials.gov · fetched Nov 12, 2026
- IbuprofenPhase 2 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- KetorolacPhase 2 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- Luer lock applicatorPhase 2 · BunionsClinicalTrials.gov · fetched Nov 12, 2026
- Luer Lock ApplicatorPhase 2 · Post-Operative PainClinicalTrials.gov · fetched Nov 12, 2026
- MMA regimenPhase 2 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- RopivacainePhase 2 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- ZYNRELEF kit components for administrationPhase 2 · Postoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- Bupivacaine HydrochlorideAnalgesiaClinicalTrials.gov · fetched Nov 12, 2026
- Bupivacaine HydrochloridePostoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- SUSTOLChemotherapy-Induced Nausea and Vomiting (CINV)ClinicalTrials.gov · fetched Nov 12, 2026
- Withdraw treatmentHealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- ZYNRELEF® for Postoperative Analgesia After Laparoscopic Sleeve GastrectomyPHASE4 · UNKNOWN · started May 9, 2023ClinicalTrials.gov NCT05863221 · fetched Nov 12, 2026
- Safety Study of Repeat Doses of SUSTOL in AdultsPHASE4 · ACTIVE_NOT_RECRUITING · started Jul 6, 2022ClinicalTrials.gov NCT05434663 · fetched Nov 12, 2026
- HTX-011 in Spinal SurgeryPHASE2 · COMPLETED · started Apr 7, 2022ClinicalTrials.gov NCT04911062 · fetched Nov 12, 2026
- Cohort 1 (TSA) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011)PHASE4 · COMPLETED · started Oct 20, 2021ClinicalTrials.gov NCT06109415 · fetched Nov 12, 2026
- A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401.PHASE4 · ACTIVE_NOT_RECRUITING · started Oct 12, 2021ClinicalTrials.gov NCT05109312 · fetched Nov 12, 2026
- Cohort 2 (Abdominoplasty) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011)PHASE4 · COMPLETED · started Oct 12, 2021ClinicalTrials.gov NCT06109428 · fetched Nov 12, 2026
- Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1)PHASE2 · TERMINATED · started Jul 20, 2020ClinicalTrials.gov NCT04470622 · fetched Nov 12, 2026
- Dose-Escalation Study of HTX-034 Following BunionectomyPHASE1_PHASE2 · COMPLETED · started May 8, 2020ClinicalTrials.gov NCT04398329 · fetched Nov 12, 2026
- PK and Safety After C-SectionPHASE2 · COMPLETED · started Jun 24, 2019ClinicalTrials.gov NCT03955211 · fetched Nov 12, 2026
- Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) RegimenPHASE3 · COMPLETED · started Jun 5, 2019ClinicalTrials.gov NCT03974932 · fetched Nov 12, 2026
- Study of Post-Herniorrhaphy Non-opioid MMA RegimensPHASE3 · COMPLETED · started Apr 4, 2019ClinicalTrials.gov NCT03907176 · fetched Nov 12, 2026
- Phase 2 Bunionectomy HTX-011 Administration StudyPHASE2 · COMPLETED · started Oct 24, 2018ClinicalTrials.gov NCT03718039 · fetched Nov 12, 2026
- Phase 2 Herniorrhaphy Study for Opioid EliminationPHASE2 · COMPLETED · started Oct 1, 2018ClinicalTrials.gov NCT03695367 · fetched Nov 12, 2026
- Bupivacaine HCl PK and Safety in Augmentation MammoplastyPHASE4 · COMPLETED · started Sep 19, 2018ClinicalTrials.gov NCT03705065 · fetched Nov 12, 2026
- Bunionectomy Study for Postoperative Analgesia (EPOCH 1)PHASE3 · COMPLETED · started Oct 24, 2017ClinicalTrials.gov NCT03295721 · fetched Nov 12, 2026
- Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)PHASE3 · COMPLETED · started Jul 31, 2017ClinicalTrials.gov NCT03237481 · fetched Nov 12, 2026
- Phase 2B Upper Extremity Nerve Block StudyPHASE2 · COMPLETED · started Jan 14, 2017ClinicalTrials.gov NCT03011333 · fetched Nov 12, 2026
- Total Knee Arthroplasty Infiltration Study for Postoperative AnalgesiaPHASE2 · COMPLETED · started Jan 13, 2017ClinicalTrials.gov NCT03015532 · fetched Nov 12, 2026
- Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following BunionectomyPHASE2 · COMPLETED · started May 1, 2016ClinicalTrials.gov NCT02762929 · fetched Nov 12, 2026
- Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty SurgeryPHASE2 · COMPLETED · started Feb 23, 2016ClinicalTrials.gov NCT02689258 · fetched Nov 12, 2026
- Pilot Herniorrhaphy Study for Postoperative AnalgesiaPHASE2 · COMPLETED · started Jul 1, 2015ClinicalTrials.gov NCT02504580 · fetched Nov 12, 2026
- HTX-011 for Post-bunionectomy AnalgesiaPHASE2 · COMPLETED · started Jun 1, 2015ClinicalTrials.gov NCT02471898 · fetched Nov 12, 2026
- A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HECPHASE3 · COMPLETED · started Mar 1, 2014ClinicalTrials.gov NCT02106494 · fetched Nov 12, 2026
- A Phase I Study of the Effects of APF530 Exposure, Granisetron and MoxifloxacinCOMPLETED · started Jul 1, 2011ClinicalTrials.gov NCT01416259 · fetched Nov 12, 2026
- APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for CancerPHASE3 · COMPLETED · started Jun 1, 2006ClinicalTrials.gov NCT00343460 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 29, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 14, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 25, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 16, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 2, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 11, 2026 · fetched Nov 12, 2026